Cuba Non Small Cell Lung Cancer Vaccine

• by EVOMT
• 2017-06-05

　　The Cuban Academy of Sciences has developed and released the world's first effective therapeutic vaccines for non small cell lung cancer - Vaxira and CIMAvax

　　The Cuban lung cancer vaccine has been approved by the FDA for clinical treatment trials in the United States:

　　This latest vaccine, which can treat non small cell lung cancer (NSCLC), has been clinically proven to have a good effect on non small cell lung cancer (NSCLC) through phase 3 clinical trials. Currently, it has entered clinical application in Cuba and Peru

　　This exciting research result led US President Barack Obama to lift the 55 year long trade ban after his visit to Cuba and introduce this latest anti cancer technology to the US in 2015.

　　The US Food and Drug Administration (FDA) has approved clinical trials of a lung cancer vaccine developed in Cuba, which can stimulate the immune system of lung cancer patients!